There were no adverse situations or changes from baseline in serologic research and critical signs in any on the contributors. The therapy's ache-relieving outcomes were confirmed by frequent, 12-7 days abide by-ups, confirming the safety and usefulness of BTX-A on Serious ON and suggesting that this method is an efficient, https://derma-solution.com/